Sub Cat. No. |
Molecular Weight |
Glycan Name |
Functional Group |
Inquiry |
X25-03-ZQ631-1 |
PEG 350 Da |
Xanthan |
MTX |
Inquiry
|
X25-03-ZQ631-2 |
PEG 550 Da |
Xanthan |
MTX |
Inquiry
|
X25-03-ZQ631-3 |
PEG 750 Da |
Xanthan |
MTX |
Inquiry
|
X25-03-ZQ631-4 |
PEG 1 kDa |
Xanthan |
MTX |
Inquiry
|
X25-03-ZQ631-5 |
PEG 2 kDa |
Xanthan |
MTX |
Inquiry
|
X25-03-ZQ631-6 |
PEG 3 kDa |
Xanthan |
MTX |
Inquiry
|
X25-03-ZQ631-7 |
PEG 4 kDa |
Xanthan |
MTX |
Inquiry
|
X25-03-ZQ631-8 |
PEG 5 kDa |
Xanthan |
MTX |
Inquiry
|
X25-03-ZQ631-9 |
PEG 10 kDa |
Xanthan |
MTX |
Inquiry
|
X25-03-ZQ631-10 |
PEG 20 kDa |
Xanthan |
MTX |
Inquiry
|
Properties
Description
This antifolate drug conjugate features methotrexate (MTX) linked to the polysaccharide xanthan via a polyethylene glycol (PEG) spacer, potentially enabling targeted drug delivery or controlled release in cancer or autoimmune disease research.
Source
Chemical synthesis
Impurities
No visible impurities to the naked eye.
Solubility
MTX-PEG-xanthan is soluble in a wide range of organic solvents, such as DCM, DMF, and DMSO, and shows excellent solubility in water.
Identity
Confirmed by NMR.
Stability
The product is stable for 1 year when stored at the recommended temperature in powder.
Quality Level
Research grade
Applications
MTX-PEG-xanthan can be used to study the behavior and delivery of this antifolate drug in non-therapeutic research models.
Storage
Store at -20°C, protect from light.